Chief Financial Officer

Chief Medical Officer

Hope for Rare Pediatric Disease Voucher Reignited as House Bill Passes Committee

Amylyx Pharmaceuticals announces pricing of $175 million underwritten public offering of common stock

Amylyx 17.5M share Spot Secondary priced at $10.00

Amylyx Pharmaceuticals Prices $175 Million Common Stock Offering

Senior Medical Director, Clinical Development

Amylyx is a clinical-stage pharmaceutical company focused on developing novel therapies for high unmet needs. They are seeking a Senior Medical Director, Clinical Development to lead late-stage clinical programs and ensure the integrity of clinical trials while collaborating with various stakeholders. The role involves medical monitoring, developing clinical study designs, and engaging with both internal teams and external experts.

Sign up with Google

Sign in with Google